US EditionNew product - Kleptose F 7% - BETA CYCLODEXTRIN - Pharma Excipients
Summary by Pharma Excipients
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
New product - Kleptose F 7% - BETA CYCLODEXTRIN - Pharma Excipients
Roquette presents a new product: KLEPTOSE® F 7% – EXP β-cyclodextrin for oral dosage forms contains less than 7% of water. It is well suited for dry processing techniques, such as direct compression, where its low water content benefits moisture-sensitive APIs and formulations (e.g., ODTs, chewables, effervescent tablets) while offering enhanced stability, solubility, and taste masking through molecular encapsulation. Kleptose F 7% – BETA CYCLO…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
